BDPC Bromadol, the newly synthetic opioid, exhibits peculiar pharmacological properties. This compound mostly functions through a limited mu binding site activator, however indicates notable activity with a kappa-opioid binding site and well. The combined influence results to the complex set regarding effects, such as pain reduction, sedation, a